Sort
30,917 grants matching “tumor microenvironment”
The role of Interleukin 17RB signaling in colorectal cancer progression
$545,797Sergei I Grivennikov · Research Inst Of Fox Chase Can Ctr · R01 · FY2020 · CA
Molecular Pathogenesis of Multiple Myeloma
$545,789Walter Kuehl · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Role of S.aureus in Cutaneous T Cell Lymphoma Pathogenesis
$545,751Sergei Borisovich Koralov · New York University School Of Medicine · R01 · FY2022 · CA
Deciphering the role of p16INK4A+ fibroblasts in lung fibrosis
$545,713Tien Peng · University Of California, San Francisco · R01 · FY2024 · HL
Non-oncogene addiction in cancer cells
$545,711Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Tech Core 2
$545,697Denis Wirtz · Johns Hopkins University · U54 · FY2023 · CA
Bispecific T cell engager targeting a highly specific tumor cell surface antigen
$545,644Bin Liu · University Of California, San Francisco · R01 · FY2025 · CA
Design of a Novel Nanocarrier Technology to Drug-Load CAR T cells
$545,643David Akhavan · University Of Kansas Medical Center · R01 · FY2024 · CA
Biophysical roles of pre-metastatic niche evolution on transport of circulating tumor cells
$545,607Kenji Yokoi · Methodist Hospital Research Institute · U01 · FY2020 · CA
Myct1 control of the angioimmune interface
$545,472Kyunghee Choi · Washington University · R01 · FY2025 · CA
Advanced Sample Preparation, Separation and Multiplexed Analysis for In-Depth Proteome Profiling of >1000 Single Cells Per Day
$545,456Ryan T Kelly · Brigham Young University · R01 · FY2025 · CA
Spatially mapping and modeling tuberculosis granulomas to define the immunological determinants of infection outcome
$545,386Erin McCaffrey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Mechanism of Activity of Lonidamine
$545,378Jerry D Glickson · University Of Pennsylvania · R01 · FY2014 · CA
Hexokinase 2 and cancer therapy
$545,313Nissim Hay · University Of Illinois At Chicago · R01 · FY2024 · CA
Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
$545,246Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2023 · CA
Bispecific T cell engager targeting a highly specific tumor cell surface antigen
$544,866Bin Liu · University Of California, San Francisco · R01 · FY2024 · CA
The tumor ecosystem in cancer progression and immunotherapeutic response
$544,850Alexander Y. Rudensky · Sloan-Kettering Inst Can Research · U54 · FY2017 · CA
Role of S.aureus in Cutaneous T Cell Lymphoma Pathogenesis
$544,847Sergei Borisovich Koralov · New York University School Of Medicine · R01 · FY2025 · CA
The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis
$544,825William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA
Characterization and Functional Analysis of Breast Cancer Secreted Exosomes in Ma
$544,810David Charles Lyden · Weill Medical Coll Of Cornell Univ · U01 · FY2013 · CA
Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors
$544,735William C Zamboni · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors
$544,735William C Zamboni · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Bitter Melon Component and Colon Cancer Prevention
$544,710Shrikant Anant · University Of Kansas Medical Center · R01 · FY2017 · CA
Bitter Melon Component and Colon Cancer Prevention
$544,710Shrikant Anant · University Of Kansas Medical Center · R01 · FY2014 · CA
Bitter Melon Component and Colon Cancer Prevention
$544,710Shrikant Anant · University Of Kansas Medical Center · R01 · FY2015 · CA